Inhibitor Therapeutics (INTI) Return on Equity [ROE] (2009 - 2025)
Inhibitor Therapeutics (INTI) recorded Return on Equity [ROE] of -952.30% in FY2025, down 860.43 percentage points from -91.87% in FY2024.
Powered by 
Analysis
Inhibitor Therapeutics (INTI) Return on Equity [ROE] (2009 - 2025) Analysis & Trends
Starting with FY2015, Inhibitor Therapeutics' Return on Equity [ROE] history includes 8 years.
- Annual Return on Equity [ROE] has declined for three straight years, with a three-year change of -1470.16 percentage points (FY2022 to FY2025).
- The FY2025 figure is the lowest annual Return on Equity [ROE] since FY2018.
- Per Business Quant data, INTI's Return on Equity [ROE] was -91.87% in FY2024 (-47.31 pp), -44.57% in FY2023 (-562.43 pp) and 517.86% in FY2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 74.39% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.63% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 21.60% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 72.13% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -31.17% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 4.66% |
| 10 | Inhibitor Therapeutics | 13.90 Mn | 6.72 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -953.10% |
| Jun 30, 2025 | -333.26% |
| Mar 31, 2025 | -197.01% |
| Dec 31, 2024 | -123.86% |
| Sep 30, 2024 | -81.77% |
| Jun 30, 2024 | -68.79% |
| Mar 31, 2024 | -63.92% |
| Dec 31, 2023 | -51.57% |
| Sep 30, 2023 | -33.70% |
| Jun 30, 2023 | -22.85% |
| Mar 31, 2023 | -13.98% |
| Dec 31, 2022 | -31.89% |
| Dec 31, 2017 | -836.93% |
| Sep 30, 2017 | -502.23% |
| Jun 30, 2017 | -391.62% |
| Mar 31, 2017 | -183.67% |
| Dec 31, 2016 | -134.74% |
| Sep 30, 2016 | -137.62% |
| Jun 30, 2016 | -239.52% |
| Mar 31, 2016 | -8,343.55% |
API Access
Inhibitor Therapeutics Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=INTI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "INTI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=INTI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();